Detailed analysis by African scientists of SARS-CoV-2 published in Science; UWARN partner Prof Tulio de Oliveira senior author
Paper published in Science by a collaboration of researchers across Africa with UWARN partner Prof. Tulio de Oliveira as the senior author. The paper demonstrates the incredible efforts of 112 African and 25 international organizations monitoring the evolution of SARS-CoV-2 in Africa through a year of genomic surveillance.
2022 CREID Pilot Program
The 2022 Pilot Program timeline has been announced. Please see the link below for additional information.
UWARN PI Wes Van Voorhis to moderate WSAS Annual Symposium
UWARN PI Wes Van Voorhis will be moderating a session at the WSAS Annual Symposium on COVID-19: Science and Society on Thursday September 23, 2021 from 10AM-4PM. More information and registration below.
UWARN co-PIs Judith Wasserheit and Peter Rabinowitz supporting TIME magazine article
UWARN PI co-author on variant immune evasion paper preprint
UWARN PI collaborates with other University of Washington researchers on a paper evaluating the SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
UWARN PI Wes Van Voorhis writes Op-Ed for Seattle Times
Wes Van Voorhis, UWARN Principle Investigator, writes Op-Ed for the Seattle Times on the rise of variants underscoring the importance of COVID-19 vaccination. The Op-Ed highlights the work on SARS-CoV-2 variants of UWARN partners Tulio de Oliveira, Luiz Carlos Junior Alcantara, and Marta Giovanetti.
UWARN Partner Tulio de Oliveira cited in NYT article on variant naming
UWARN Partner Michel Nussenzweig cited in New York Times article on B.1.526 SARS-CoV-2 variant
UWARN partner Tulio de Oliveira highlighted in NIH Director's Blog
UWARN highlighted in UW Department of Global Health news
UWARN highlighted in UW Department of Global Health news for the collaborative effort among UWARN partners to understand new SARS-CoV-2 variants and implications for vaccine efficacy.
UWARN Partner Tulio de Oliviera cited in New York Times
UWARN Partner Tulio de Oliviera of the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP) at the University of KwaZulu-Natal cited in New York Times article on the evolving SARS-CoV-2 viruses and British lockdown
